Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Prager

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Wiener Medizinische Wochenschrift (1946)|July 31, 1988
[Pathogenesis and therapy of type I and type II diabetes mellitus]R Prager
Wiener Medizinische Wochenschrift. Supplement|January 1, 1989
[Treatment of hyperlipidemia with HMG-CoA reductase inhibitors]R Prager
Acta Medica Austriaca|January 1, 1995
[Obesity: physiology and possibilities for treatment]R Prager
Radiologia Clinica Et Biologica|January 1, 1973
Vertebral fixation of the oesophagus. A symptom in the posterior mediastinumG R Prager
Zeitschrift Fur Urologie Und Nephrologie|July 1, 1984
[Genetic causes of possible pathogenicity factors of urinary tract strains (E. coli)]H Tschäpe, R Prager
Acta Medica Austriaca|January 1, 1984
[Insulin receptor and postreceptor disorders: significance for the development and therapy of carbohydrate metabolic disorders]G Schernthaner, R Prager
Diabetologia|September 1, 1983
Insulin binding of human and porcine monocomponent insulin to monocytes in type 1 (insulin-dependent) diabetic patients and control subjectsR Prager, G Schernthaner
Osterreichische Zeitschrift Fur Stomatologie|September 1, 1983
[Facial and mediastinal emphysema after tooth extraction]L Ertl, R Prager
Wiener Medizinische Wochenschrift (1946)|July 4, 2002
[Reduction of cardiovascular morbidity and mortality by combined antihypertensive drug therapy in patients with type 2 diabetes mellitus]Heidemarie Abrahamian, R Prager
Diabetes Care|November 1, 1982
Receptor binding properties of human insulin (recombinant DNA) and human proinsulin and their interaction at the receptor siteR Prager, G Schernthaner
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Wiener Medizinische Wochenschrift (1946)|July 31, 1988
[Pathogenesis and therapy of type I and type II diabetes mellitus]R Prager
Wiener Medizinische Wochenschrift. Supplement|January 1, 1989
[Treatment of hyperlipidemia with HMG-CoA reductase inhibitors]R Prager
Acta Medica Austriaca|January 1, 1995
[Obesity: physiology and possibilities for treatment]R Prager
Radiologia Clinica Et Biologica|January 1, 1973
Vertebral fixation of the oesophagus. A symptom in the posterior mediastinumG R Prager
Zeitschrift Fur Urologie Und Nephrologie|July 1, 1984
[Genetic causes of possible pathogenicity factors of urinary tract strains (E. coli)]H Tschäpe, R Prager
Acta Medica Austriaca|January 1, 1984
[Insulin receptor and postreceptor disorders: significance for the development and therapy of carbohydrate metabolic disorders]G Schernthaner, R Prager
Diabetologia|September 1, 1983
Insulin binding of human and porcine monocomponent insulin to monocytes in type 1 (insulin-dependent) diabetic patients and control subjectsR Prager, G Schernthaner
Osterreichische Zeitschrift Fur Stomatologie|September 1, 1983
[Facial and mediastinal emphysema after tooth extraction]L Ertl, R Prager
Wiener Medizinische Wochenschrift (1946)|July 4, 2002
[Reduction of cardiovascular morbidity and mortality by combined antihypertensive drug therapy in patients with type 2 diabetes mellitus]Heidemarie Abrahamian, R Prager
Diabetes Care|November 1, 1982
Receptor binding properties of human insulin (recombinant DNA) and human proinsulin and their interaction at the receptor siteR Prager, G Schernthaner
Pageof 22